SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently a major focus of community debate, with proponents highlighting its evolution into a broader blockchain ecosystem and long-term potential, while critics dismiss it as a stagnant project and speculate on its future viability. The conversation remains highly polarized, driven by a mix of intense speculation, calls for increased token burns, and ongoing comparisons to other meme coin competitors.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is facing intense volatility as investors debate the transition from a volatile procurement-heavy business model toward higher-margin AI systems integration. While the community remains divided over the lack of public relations and heavy insider selling, bulls are aggressively accumulating shares, betting that institutional backing and deep ties to Dell's AI infrastructure buildout will trigger a significant rerating once earnings momentum accelerates.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently trending due to intense downward price volatility and building frustration among investors as the asset hits multi-year lows. The community is sharply divided, with some expressing deep skepticism over the project's long-term viability, while others aggressively advocate for dollar-cost averaging in anticipation of a future recovery.

Horizon Quantum Holdings Ltd. engages in the development of software tools. The company is headquartered in Singapore.

Horizon Quantum Holdings Ltd. - Ordinary Shares - Class A

Horizon Quantum Holdings is seeing significant volatility and intense trading volume driven by its status as a newly public, low-float quantum software play with backing from major industry players like IONQ and Dell. Community members are actively debating the company's competitive positioning, comparing its proprietary software approach to established hardware-integrated firms, while many speculators are closely monitoring lock-up periods and potential short squeeze dynamics.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is capturing investor interest as a dual-play on gold and copper, with community discussion highlighting its strategic position in mining infrastructure and potential value unlock from a planned North American IPO. While rising operational costs and geopolitical tensions weigh on the sector, sentiment is bolstered by robust free cash flow and a significant authorized share repurchase program, keeping the stock a central focus for commodity-driven portfolios.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is currently trending as investors scrutinize its upcoming Q1 earnings report following aggressive share buybacks and a significant increase in institutional interest from firms like Vanguard and Uber. Community discourse centers on a disconnect between the company's expanding global footprint in Europe, the UAE, and China versus its stagnant stock price, with market participants eagerly awaiting concrete revenue guidance and details on its multi-platform ADAS scaling strategy.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

Investors are actively flocking to JEPQ, driven by its dual appeal of monthly cash flow through covered-call strategies and ongoing exposure to Nasdaq-100 growth. The community remains heavily focused on dividend sustainability and yield comparison against peer funds, using the ETF as a core component for long-term income generation.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is currently trending as investors weigh strong demand and backlog growth against recent stock offerings that have caused volatility. The community remains divided between those viewing the power infrastructure specialist as a long-term pick-and-shovel play for the AI data center boom and those frustrated by management's equity financing decisions.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is garnering intense community focus as traders debate the project's long-term utility in powering institutional finance through CCIP and RWA tokenization versus its sluggish price action relative to Bitcoin. The conversation is currently split between bulls betting on structural adoption by major financial institutions and bears who remain frustrated by the token's persistent supply-side headwinds and stagnant market performance.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending as investors digest the departure of its former Chief Medical Officer following investigative reports, a development the community largely views as an emotional headline that does not impair the core clinical trial data for NXC-201. Discussion is heavily focused on the company's strong institutional backing and the upcoming September data release as the primary catalyst for a potential rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff Nears

Equity

SLS leads in stock momentum, while MLTX is cheaper and better-funded, with nearly $300 million in cash at the end of the first quarter.

MoonLake Immunotherapeutics' CFO Sells 39K Shares

Key PointsThe executive sold 39,120 shares on June 22...

MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa

MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa...

Why MoonLake Immunotherapeutics Stock Wilted on Wednesday

Key PointsIt aims to raise up to $200 million in the offering...

MLTX Stock Extends Pullback After Biggest Rally In Over 6 Months Following Skin Disease Trial Data — A Look At The Latest Development

The biotech firm upsized its offering to $200 million, up from the previously announced $150 million.

MLTX Stock Clocks Best Day In Over 6 Months — What’s Driving The Investor Optimism? 

Clear Street described sonelokimab’s profile in hidradenitis suppurativa as highly competitive and one that readily supports “blockbuster potential.”


Why Is MoonLake Immunotherapeutics Stock Soaring Monday?

MoonLake reported durable one-year Phase 3 hidradenitis suppurativa data for sonelokimab and plans an FDA filing in September 2026.read more...

S&P 500, Nasdaq, Dow Futures Slip After Trump Warns Iran Of Fresh Strikes Over Hormuz Standoff: INTC, MLTX, SNDK, KEEL In Focus

Iran argued that Washington had failed to uphold commitments to curb hostilities in Lebanon. 

Why Is MLTX Stock Rallying Nearly 20% Overnight?

Key upcoming catalysts include MoonLake's Investor Day on Monday, an FDA filing in September, and additional late-stage pipeline readouts later this year.

MLTX Stock Moves Higher As Traders Position For Late-Stage Trial Catalysts

Moonlake’s lead drug Sonelokimab is being tested across inflammatory conditions, with the biggest near-term focus on hidradenitis suppurativa. 

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$19.02
Prev Close	$19.36
Open	$19.48
Dividend Yield	0.00%
50-Day Moving Average	$18.93
Beta	0.65
Avg. Volume	1.31M
PE Ratio	-4.91

52-Week High	$62.75
52-Week Low	$5.95
Market Capitalization	$1.6B
EPS (Annual)	-$3.53
Price to Book	5.40
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

MLTXMoonLake Immunotherapeutics

Latest MLTX News